Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 181 to 190 of 383 resources
-
WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.UK, Rest of World Apr 2016 Other, Strategy & Planning PDF -
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.
It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.England Apr 2016 Reports & Research PDF -
Hepatitis C ODNs and Clinical Leads
Operational Delivery Networks (ODNs) are the new structures through which hepatitis C treatment in England is being delivered. The Network involves regional centres which manage treatment decisions and prescribing, and which have a dispersed treatment model which aims to support partnership working and access for local patients.
This graphic details each ODN across England, along with the named ODN Clinical Lead for each.England Apr 2016 Other, Strategy & Planning PDF -
Guidance: Hepatitis C prevention, diagnosis and treatment in prisons in England
This document, published by The Hepatitis C Trust after convening an expert group of prison healthcare commissioners and practitioners, provides commissioners and prison healthcare teams with practical guidance regarding the implementation of opt-out BBV testing and related hepatitis C care pathways, which can be adapted and used by any prison that needs to develop, revise or update their services.UK, England Mar 2016 Reports & Research, Tools & Templates, Strategy & Planning PDF -
The blood borne virus opt-out testing policy for prisons in England: An analysis of need towards full implementation
In recognition of the exceptionally high prevalence of blood borne viruses (BBVs), in particular hepatitis C, amongst people in prisons and previously very low rates of testing, in October 2013 Public Health England (PHE), NHS England and the National Offender Management Service (NOMS) agreed to introduce opt-out testing for hepatitis B, hepatitis C and HIV across the prison estate by 2016/17.UK, England Mar 2016 Reports & Research, Strategy & Planning PDF -
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
This article uses the example of Switzerland to look at how recent developments in hepatitis C therapy might impact upon the prevention of hepatitis C vertical (i.e. mother to baby) transmission. It finds that universal screening for hepatitis C among pregnant women should be urgently re-evaluated in the light of the new treatments which are now available.Rest of World Feb 2016 Reports & Research PDF -
Building the Momentum: Making the Case: World Hepatitis Summit 2015 meeting report
On 2nd - 4th September 2015 in Glasgow, the World Hepatitis Alliance staged the first ever World Hepatitis Summit in conjunction with the World Health Organisation and the Scottish Government. Over eighty countries were represented at the Summit which brought together delegates from national governments, World Hepatitis Alliance member organisations, public health and the pharmaceutical industry.Rest of World Feb 2016 Reports & Research, Strategy & Planning PDF -
Scottish National Clinical Guidelines for the treatment of HCV in adults
These guidelines, published by Health Improvement Scotland and NHS National Services Scotland, provide guidance to Health Board Area Drug and Therapeutics Committees on the recommended use of available hepatitis C drugs, taking into consideration Scottish Medicines Consortium guidance, clinical effectiveness and price.UK, Scotland Feb 2016 Other, Strategy & Planning PDF -
Northern Ireland Regional Hepatitis B & C Managed Clinical Network Annual Report 2015
This report, published by the Northern Ireland Hepatitis B & C Managed Clinical Network, provides an overview of the progress made by the Network in tackling hepatitis C in Northern Ireland, as well as providing a wider overview of the virus' impact in the country. As well as highlighting broader work, it also provides details of a pilot which involved a hepatitis B and C screening event aimed at the Chinese community in Belfast.UK, Northern Ireland Feb 2016 Reports & Research PDF -
HCV Action good practice case study: Outreach fibroscanning and testing by Imperial College Healthcare NHS Trust
Many people with hepatitis C who access drug and alcohol services face barriers to accessing secondary care. In order to enable this group to have access to specialist services in an environment in which they felt comfortable, the Imperial College Healthcare NHS Trust developed a bespoke outreach fibroscan and testing service for the assessment of hepatitis C and liver disease. The service has operated in drug and alcohol services and homeless hostels, targeting people who may find it otherwise difficult to access secondary care.UK, Greater London Dec 2015 Case study PDF